Fostemsavir
Rukobia (fostemsavir) is a small molecule pharmaceutical. Fostemsavir was first approved as Rukobia on 2020-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. The pharmaceutical is active against Envelope surface glycoprotein gp160, precursor. Rukobia's patent is valid until 2027-11-19 (FDA).
| Trade Name | Rukobia |
|---|---|
| Common Name | Fostemsavir |
| Indication | hiv infections |
| Drug Class | Antivirals; phosphoro-derivatives |
